Multiple Manufacturers

MITOXANTRONE HCL

Manufacturer:

Multiple Manufacturers

Mitoxantrone Hcl HCPCS:

J9293

HCPCS Code Descriptor:

Injection, mitoxantrone hydrochloride, per 5 mg

Category:

J Code

Mitoxantrone Hcl NDCs:

63323-0132-15, 63323-0132-12, 63323-0132-10, 61703-0343-66, 61703-0343-65, 61703-0343-18

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Mitoxantrone Hcl:

MITOXANTRONE HCL is an Oncology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J9293 is aligned to the drug MITOXANTRONE HCL.

ACCESS PRICING AND MORE BY REGISTERING

J9293 Added Date:

January 1, 1990

J9293 Effective Date:

January 1, 1997

J9293 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Mitoxantrone Hcl billing and coding information.
Our team did not identify a source for Mitoxantrone Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for MITOXANTRONE HCL
Our team has not yet identified a source of side effects information for MITOXANTRONE HCL. Please check back in a few weeks.